Intrahepatic Cholangiocarcinoma  >>  albumin-bound paclitaxel  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
albumin-bound paclitaxel / Generic mfg.
NCT02181634 / 2015-002066-24: Phase II Trial of Nab-Paclitaxel and Gemcitabine for First-Line Treatment of Patients With Cholangiocarcinoma

Completed
2
74
US, Europe
Nab-Paclitaxel and Gemcitabine, Abraxane®, Cytotoxic Antimicrotubular, Gemzar®, Pyrimidine Antimetabolite
PrECOG, LLC., Celgene Corporation
Cholangiocarcinoma
09/16
10/17

Download Options